TGFB1 and colonic neoplasm: To establish a lncRNAs‐based model that could be used for improving the relapse risk prediction and tailoring therapies, we specially identified lncRNAs that were significantly associated with both cancer prognosis and biological processes including angiogenesis, hypoxia, TGFβ signalling and epithelial‐mesenchymal transformation (EMT), which have been well‐studied in multiple solid tumours, and defined as important stroma‐related factors mediating tumour metastasis and drug resistance, including in colon cancer.16, 17, 18